Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3 + dendritic cells

Thijs W. H. Flinsenberg, Ewoud B. Compeer, Dan Koning, Mark Klein, Femke J. Amelung, Debbie van Baarle, Jaap Jan Boelens, Marianne Boes

Blood (2012) 120 (26): 5163–5172.

https://doi.org/10.1182/blood-2012-06-434498

Published: 2012

Includes: Supplemental data

Journal Articles

Identification of New Hematopoietic Minor Histocompatibility Antigen UTA2-1; Ready for Application in Antitumor Immunotherapy

Rimke Oostvogels, MD, Monique C. Minnema, MD PhD, Maureen van Elk, Robbert M Spaapen, PhD, Debbie van Baarle, PhD, Eric Spierings, PhD, Henk M. Lokhorst, MD, Tuna Mutis, MD PhD

Blood (2011) 118 (21): 2979.

https://doi.org/10.1182/blood.V118.21.2979.2979

Published: 2011

Journal Articles

Prognostic value of HIV-1 Gag-specific CD4 + T-cell responses for progression to AIDS analyzed in a prospective cohort study

Christine A. Jansen, Iris M. De Cuyper, Berend Hooibrink, Akke K. van der Bij, Debbie van Baarle, Frank Miedema

Blood (2006) 107 (4): 1427–1433.

https://doi.org/10.1182/blood-2005-07-2907

Published: 2006

Journal Articles

Loss of EBNA1-specific memory CD4 + and CD8 + T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma

Erwan Piriou, Karel van Dort, Nening M. Nanlohy, Marinus H. J. van Oers, Frank Miedema, Debbie van Baarle

Blood (2005) 106 (9): 3166–3174.

https://doi.org/10.1182/blood-2005-01-0432

Published: 2005

Journal Articles

Loss of EBV-Specific CD4 + T Cells during Progression to EBV-Related AIDS Non-Hodgkin Lymphoma: Restoration by Highly Active Antiretroviral Therapy (HAART).

Erwan R. Piriou, Christine Jansen, Karel van Dort, Iris De Cuyper, Nening M. Nanlohy, Joep M. Lange, MD, PhD, Frank Miedema, PhD, Marinus H.J. Van Oers, MD, PhD, Debbie van Baarle, PhD

Blood (2004) 104 (11): 3110.

https://doi.org/10.1182/blood.V104.11.3110.3110

Published: 2004

Journal Articles

Impaired recovery of Epstein-Barr virus (EBV)—specific CD8 + T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

Pauline Meij, Joost W. J. van Esser, Hubert G. M. Niesters, Debbie van Baarle, Frank Miedema, Neil Blake, Alan B. Rickinson, Ingrid Leiner, Eric Pamer, Bob Löwenberg, Jan J. Cornelissen, Jan W. Gratama

Blood (2003) 101 (11): 4290–4297.

https://doi.org/10.1182/blood-2002-10-3001

Published: 2003

Journal Articles

Persistent numbers of tetramer + CD8 + T cells, but loss of interferon-γ + HIV-specific T cells during progression to AIDS

Stefan Kostense, Kristin Vandenberghe, Jeanine Joling, Debbie Van Baarle, Nening Nanlohy, Erik Manting, Frank Miedema

Blood (2002) 99 (7): 2505–2511.

https://doi.org/10.1182/blood.V99.7.2505

Published: 2002

Journal Articles

Dysfunctional Epstein-Barr virus (EBV)–specific CD8 + T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma

Debbie van Baarle, Egbert Hovenkamp, Margareth F. C. Callan, Katja C. Wolthers, Stefan Kostense, Linda C. Tan, Hubert G. M. Niesters, Albert D. M. E. Osterhaus, Andrew J. McMichael, Marinus H. J. van Oers, Frank Miedema

Blood (2001) 98 (1): 146–155.

https://doi.org/10.1182/blood.V98.1.146

Published: 2001

Journal Articles

Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome–Related Non-Hodgkin’s Lymphoma

Debbie van Baarle, Egbert Hovenkamp, Marie José Kersten, Michèl R. Klein, Frank Miedema, Marinus H.J. van Oers

Blood (1999) 93 (11): 3949–3955.

https://doi.org/10.1182/blood.V93.11.3949

Published: 1999

NARROW

Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3 + dendritic cells

Identification of New Hematopoietic Minor Histocompatibility Antigen UTA2-1; Ready for Application in Antitumor Immunotherapy

Prognostic value of HIV-1 Gag-specific CD4 + T-cell responses for progression to AIDS analyzed in a prospective cohort study

Loss of EBNA1-specific memory CD4 + and CD8 + T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma

Loss of EBV-Specific CD4 + T Cells during Progression to EBV-Related AIDS Non-Hodgkin Lymphoma: Restoration by Highly Active Antiretroviral Therapy (HAART).

Impaired recovery of Epstein-Barr virus (EBV)—specific CD8 + T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

Persistent numbers of tetramer + CD8 + T cells, but loss of interferon-γ + HIV-specific T cells during progression to AIDS

Dysfunctional Epstein-Barr virus (EBV)–specific CD8 + T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma

Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome–Related Non-Hodgkin’s Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only